
GLP-1R Agonist DMB
CAS No. 281209-71-0
GLP-1R Agonist DMB( —— )
Catalog No. M34861 CAS No. 281209-71-0
GLP-1R Agonist DMB is an agonist of glucagon-like peptide 1 receptor (GLP-1R; KB = 26.3 nM for the recombinant human receptor).
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 71 | In Stock |
![]() ![]() |
5MG | 136 | In Stock |
![]() ![]() |
10MG | 237 | In Stock |
![]() ![]() |
25MG | 391 | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameGLP-1R Agonist DMB
-
NoteResearch use only, not for human use.
-
Brief DescriptionGLP-1R Agonist DMB is an agonist of glucagon-like peptide 1 receptor (GLP-1R; KB = 26.3 nM for the recombinant human receptor).
-
DescriptionGLP-1R agonist 2 (compound 2) is a potent GLP-1R agonist. GLP-1R agonist 2 has the potential for the research of metabolic diseases like Type2 Diabetes and Obesity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetGlucagon Receptor
-
RecptorGlucagon Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number281209-71-0
-
Formula Weight348.25
-
Molecular FormulaC13H15Cl2N3O2S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 25 mg/mL (71.79 mM; Ultrasonic (<60°C)
-
SMILESCC(C)(C)Nc1nc2cc(Cl)c(Cl)cc2nc1S(C)(=O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference



-
GRA Ex-25
A potent glucagon receptor inhibitor with IC50 of 56 and 55 nM for rat and human glucagon receptors.
-
des-His1-[Glu9]-Gluc...
Glucagon receptor antagonist (pA2 = 7.2 for inhibition of glucagon-induced adenylyl cyclase activation in rat liver membranes); displays no agonist activity. Enhances glucose-stimulated pancreatic insulin release in vitro. Blocks added glucagon-induced hyperglycemia in normal rabbits without affecting glycogenolysis in vivo. Also blocks endogenous glucagon-induced hyperglycemia in streptozocin diabetic rats.
-
Retatrutide
Retatrutide (LY3437943) is a triple agonist of the glucagon receptor, glucose-dependent insulinotropic polypeptide receptor, and glucagon-like peptide-1 receptor (GLP-1R), and inhibits GCGR, GIPR, and GLP-1R.Retatrutide can be used to study obesity.